|
Market Closed -
Nasdaq
04:00:00 05/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 29.66 USD | +0.68% |
|
+1.16% | +7.00% |
| 09-01 | Beam Therapeutics Inc. Appoints Eric Foster as Chief Commercial Officer | CI |
| 08-20 | Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder | RE |
| Market Cap | 2.96B 2.55B 2.4B 2.19B 4.1B 280B 4.11B 28.35B 11B 144B 11.13B 10.89B 463B | P/E 2026 * |
-6.71x | P/E 2027 * | -6.21x |
|---|---|---|---|---|---|
| Enterprise Value | 2.05B 1.76B 1.66B 1.51B 2.83B 193B 2.84B 19.59B 7.6B 99.18B 7.69B 7.52B 320B | EV / Sales 2026 * |
42.2x | EV / Sales 2027 * | 27.8x |
| Free-Float |
98.63% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BEAM | Delayed | |
CBOE
| BEAM | Real-time | |
|
Mexican S.E.
| BEAM * | End-of-day quote |
Last Transcript : Beam Therapeutics Inc.
| 1 day | +0.68% | ||
| 1 week | +1.16% | ||
| Current month | +0.78% | ||
| 1 month | +9.57% | ||
| 3 months | +0.88% | ||
| 6 months | +16.22% | ||
| Current year | +7.00% |
| 1 week | 28.02 |  | 30.18 |
| 1 month | 25.71 | | 31.48 |
| Current year | 21.63 | | 38.26 |
| 1 year | 19.36 | | 38.26 |
| 3 years | 13.52 | | 49.5 |
| 5 years | 13.52 | | 116.91 |
| 10 years | 13 | | 138.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Evans
CEO | Chief Executive Officer | 48 | 01/01/2017 |
Sravan Emany
DFI | Director of Finance/CFO | 48 | 19/12/2024 |
| President | 57 | 24/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
John Evans
BRD | Director/Board Member | 48 | 01/01/2017 |
Mark Fishman
BRD | Director/Board Member | 75 | 01/05/2018 |
Graham Cooper
BRD | Director/Board Member | 56 | 10/10/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/7/26 | Sell | Chief Technology Officer | -16,667 | 0.0162% | ||
| 30/6/26 | Exercice | Chief Executive Officer | 75,000 | 0.0729% | ||
| 30/6/26 | Sell | Chief Technology Officer | -373 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.68% | +1.16% | +42.05% | +25.25% | 2.96B | |
| -2.54% | -2.84% | -1.77% | +14.72% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +523.39% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +21.22% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +74.90% | 40.73B | |
| +0.53% | -1.36% | +16.87% | +47.12% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +123.04% | 16.5B | |
| -1.01% | +0.50% | +13.91% | +31.45% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.22% | 13.77B | |
| Average | -0.76% | +0.60% | +70.50% | +100.26% | 27.8B | |
| Weighted average by Cap. | -1.01% | +0.12% | +88.88% | +126.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 48.57M 41.8M 39.32M 35.92M 67.2M 4.59B 67.38M 465M 180M 2.35B 182M 178M 7.58B | 62.75M 54M 50.8M 46.41M 86.81M 5.92B 87.05M 600M 233M 3.04B 236M 230M 9.79B |
| Net income | -462M -397M -374M -342M -639M -43.61B -641M -4.42B -1.71B -22.37B -1.73B -1.7B -72.07B | -537M -462M -434M -397M -742M -50.66B -744M -5.13B -1.99B -25.99B -2.01B -1.97B -83.73B |
| Net Debt | -916M -789M -742M -678M -1.27B -86.52B -1.27B -8.77B -3.4B -44.39B -3.44B -3.37B -143B | -1.22B -1.05B -989M -903M -1.69B -115B -1.69B -11.69B -4.54B -59.18B -4.59B -4.49B -191B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | US$29.66 | +0.68% | 1,183,164 |
| 03/09/26 | US$29.46 | +0.58% | 1,271,298 |
| 02/09/26 | US$29.29 | +0.93% | 1,293,353 |
| 01/09/26 | US$29.02 | -1.39% | 889,435 |
| 31/08/26 | US$29.43 | +0.38% | 1,308,774 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BEAM Stock
Select your edition
All financial news and data tailored to specific country editions
